1. Home
  2. WST vs CSL Comparison

WST vs CSL Comparison

Compare WST & CSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • CSL
  • Stock Information
  • Founded
  • WST 1923
  • CSL 1917
  • Country
  • WST United States
  • CSL United States
  • Employees
  • WST N/A
  • CSL N/A
  • Industry
  • WST Medical/Dental Instruments
  • CSL Specialty Chemicals
  • Sector
  • WST Health Care
  • CSL Industrials
  • Exchange
  • WST Nasdaq
  • CSL Nasdaq
  • Market Cap
  • WST 20.1B
  • CSL 16.2B
  • IPO Year
  • WST N/A
  • CSL N/A
  • Fundamental
  • Price
  • WST $262.45
  • CSL $298.40
  • Analyst Decision
  • WST Strong Buy
  • CSL Buy
  • Analyst Count
  • WST 9
  • CSL 6
  • Target Price
  • WST $354.50
  • CSL $386.67
  • AVG Volume (30 Days)
  • WST 784.7K
  • CSL 527.1K
  • Earning Date
  • WST 10-23-2025
  • CSL 10-29-2025
  • Dividend Yield
  • WST 0.34%
  • CSL 1.46%
  • EPS Growth
  • WST 0.17
  • CSL N/A
  • EPS
  • WST 6.75
  • CSL 17.56
  • Revenue
  • WST $3,017,900,000.00
  • CSL $5,015,100,000.00
  • Revenue This Year
  • WST $6.97
  • CSL $1.17
  • Revenue Next Year
  • WST $6.11
  • CSL $2.98
  • P/E Ratio
  • WST $38.87
  • CSL $17.11
  • Revenue Growth
  • WST 4.92
  • CSL 0.14
  • 52 Week Low
  • WST $187.43
  • CSL $298.30
  • 52 Week High
  • WST $348.90
  • CSL $472.66
  • Technical
  • Relative Strength Index (RSI)
  • WST 41.18
  • CSL 26.47
  • Support Level
  • WST $258.93
  • CSL $312.66
  • Resistance Level
  • WST $280.11
  • CSL $326.76
  • Average True Range (ATR)
  • WST 9.12
  • CSL 10.70
  • MACD
  • WST -3.12
  • CSL -1.89
  • Stochastic Oscillator
  • WST 11.89
  • CSL 0.87

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About CSL Carlisle Companies Incorporated

Carlisle Companies Inc is a holding company. The company manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. The company is organized into two segments including Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company's product portfolio includes moisture protection products, protective roofing underlayments, integrated air and vapor barriers, spray polyurethane foam and coating systems, and others. The majority of the company's revenue comes from the Carlisle Construction Materials segment, and more than half of the total revenue is earned in the United States.

Share on Social Networks: